Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib Combined With IMRT in Nasopharyngeal Cancer
NCT01534585Phase 2Completed
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in nasopharyngeal carcinoma (NPC), sponsored by Taizhou Hospital of Zhejiang Province. Started Feb 2012; status: completed.
02
Drugs
icotinib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01534585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534585.